In June 2026, the US IPO market reached a record high with 19 offerings raising $97.9 billion, a massive jump from $13.1 billion in May and $4.2 billion a year earlier. This surge was driven by Space Exploration Technologies Corp. (SpaceX), whose IPO was described as 'out of this world.' Healthcare company Parabilis Medicines also stood out with a 58% first-day price increase after pricing above its initial range. This record activity signals strong investor appetite and could encourage more companies to go public soon.
SpaceX canceled the planned test flight of its upgraded Starship V3 rocket due to engine start failures, causing an automatic abort. This was the first flight attempt since the rocket's May launch, which ended with a booster mishap. The Federal Aviat...
Short sellers have sharply increased their bets against SpaceX, with about 185 million shares sold short, representing nearly 29% of the company's public float and around $25 billion in bearish wagers. This surge follows the stock's decline of about ...
Space Exploration Technologies (SPCX) stock has experienced early volatility, falling slightly below its IPO price of $135. Despite this, Morgan Stanley analysts have set a $225 price target, indicating a 66% potential gain. The company is investing ...
SpaceX shares fell below their IPO price of $135 for the first time, dropping to $132.28 before closing slightly above at $135.27. The stock is down about 16% from its June 12 closing price and 36% from its peak on June 16. The decline reflects inves...
SpaceX shares dropped below their initial public offering (IPO) price of $135 for the first time after falling for four consecutive sessions. The stock has been volatile since its historic IPO last month, which raised a record $86 billion and made El...
